Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Phase I Study of ACTR087, Autologous T Lymphocytes Expressing Antibody Couple T-Cell Receptors (CD16V-41BB-CD35), in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma

Research Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Unum Therapeutics Inc.

Start Date

December 5, 2016

End Date

March 16, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Unum Therapeutics Inc.

Start Date

December 5, 2016

End Date

March 16, 2021